医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GenoLogics Releases Clarity LIMS X as Part of Illumina SeqLab

2015年07月21日 PM09:00
このエントリーをはてなブックマークに追加


 

REDWOOD CITY, Calif.

GenoLogics today announced the availability of Clarity LIMS X, an edition of its industry-leading laboratory informatics platform. Optimized for use with Illumina® SeqLab, the X Edition of Clarity LIMS provides positive sample tracking, maximizes quality and throughput, and improves turnaround time in population-scale genomics workflows.

The 2014 launch of the HiSeq X systems enabled labs to break the $1,000 barrier for human whole-genome sequencing. Labs are now addressing how to scale to groundbreaking throughput while maintaining a focus on quality and accuracy. The X Edition provides rapid scaling with automation and business logic built into preconfigured HiSeq X Series workflows. Samples advance through the pipeline automatically, minimizing human interaction and the potential for error while enforcing quality standards. The X Edition of Clarity LIMS was designed based upon best practices from Genomics England Lab (GEL) and the Illumina FastTrack Services Lab, and is currently in use in both labs.

Clarity LIMS X Edition also provides e-signature, audit trails, and patient data security, making it suitable for regulated environments. According to Illumina Director of Scientific Research, Ryan Taft, Ph.D., “Clarity LIMS X closes the gap in providing a commercially available LIMS that includes out of the box instrument integration and positive sample tracking.”

“We are proud to partner with Illumina to provide the X Edition of Clarity LIMS for Illumina SeqLab,” says Michael Ball, CEO of GenoLogics. He adds, “This solution empowers scientists and clinicians to advance the understanding of disease and accelerate the integration of genomics into everyday healthcare.”

About GenoLogics

GenoLogics develops the industry-leading laboratory information management system (LIMS) for life sciences organizations. All Clarity LIMS editions help labs gain efficiencies and throughput with increased accuracy, fast turnaround, sample traceability, and preconfigured instrument integrations. Whether labs are regulated or unregulated, big or small, Clarity LIMS streamlines operations so that life sciences organizations can focus on advancing healthcare. In 2014, GenoLogics was independently awarded the Frost & Sullivan Customer Leadership Award in the area of Next Generation Sequencing Informatics. Founded in 2002 and privately held, GenoLogics has offices in Canada, U.S., and Europe. www.genologics.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20150721005207/en/

CONTACT

GenoLogics Life Sciences Software
Lisa Owen, +1-250-483-7011
Communications
Manager
lisa.owen@genologics.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表